BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program | O BJA 2026 172702

FAQs: BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program (COSSUP)

What is the BJA FY 2026 COSSUP grant?

The Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program (COSSUP) is a discretionary grant opportunity from the U.S. Department of Justice, Bureau of Justice Assistance (BJA). It is designed to help jurisdictions build, strengthen, or expand coordinated, on-the-ground responses to overdose deaths and the broader harms associated with illicit opioids, stimulants, and other substances.

What is the main purpose of COSSUP funding?

COSSUP funding is intended to support comprehensive, site-based strategies that bring together public safety, public health, and community partners. The goal is to help communities respond across the full continuum of need: prevention, enforcement, treatment, and long-term recovery support.

What does "site-based" mean in this program?

Based on the opportunity description, "site-based" refers to practical, implementation-oriented efforts that are grounded in a specific jurisdiction or community setting and carried out through coordinated local partnerships (public safety, public health, and community partners) to address local overdose and substance use harms.

What kinds of substances does COSSUP focus on?

The program focuses on illicit opioids, stimulants, and other substances connected to overdose deaths and related community harms.

Does the program support both public safety and public health approaches?

Yes. COSSUP is positioned as a comprehensive approach that aligns enforcement efforts against illicit distribution with prevention, overdose reversal capacity, and evidence-informed treatment and recovery supports.

What types of law enforcement activities can be supported?

On the law enforcement side, COSSUP can support activities that help agencies locate, disrupt, and investigate unlawful distribution networks tied to opioids and other illicit drugs.

Does COSSUP support overdose prevention and harm reduction activities?

Yes. The program explicitly supports efforts that increase access to prevention programming and overdose reversal medications. The opportunity description gives an example of expanding naloxone availability and use, and emphasizes that immediate overdose response and harm reduction are essential to reducing preventable deaths.

Can COSSUP funds be used to expand naloxone availability?

Yes. Expanding naloxone availability and use is specifically referenced as an example of increasing access to overdose reversal medications.

Does the program include treatment and recovery support?

Yes. COSSUP emphasizes expanding treatment and recovery support services in the community and also within correctional settings and during reentry.

Are correctional settings and reentry activities part of the program focus?

Yes. The description highlights treatment and recovery support services within correctional settings and during reentry, noting that overdose risk often increases following release and that continuity of care can be life-saving.

Who is eligible to apply for this grant?

Eligible applicants include state governments, territorial governments, county governments, city or township governments, special district governments, and federally recognized Native American tribal governments.

Are smaller local jurisdictions (like towns or villages) eligible?

Yes. The opportunity clarifies eligibility for "other units of local government," described as general-purpose political subdivisions such as towns, boroughs, parishes, and villages.

Why does the opportunity emphasize "other units of local government"?

The description indicates this framing is intended to ensure that a wide range of local jurisdictions, not just large cities or counties, can apply and tailor a response to local drug trends, capacity, and community needs.

What is the funding instrument type for this opportunity?

The funding instrument type is a grant.

What is the activity category for this opportunity?

The opportunity is within the Law, Justice and Legal Services activity category.

What is the CFDA number associated with this program?

The CFDA number listed for this program is 16.838.

What is the funding opportunity number?

The funding opportunity number is O-BJA-2026-172702.

What is the maximum award amount?

The award ceiling (maximum award amount) is $7,000,000 per award.

When is the application deadline?

The original application closing date is September 24, 2026.

What overall approach does the NOFO position COSSUP to support?

The NOFO positions COSSUP as a major funding vehicle for jurisdictions that want to coordinate enforcement against illicit distribution with prevention, overdose reversal capacity, and evidence-informed treatment and recovery supports, including services that begin or continue inside correctional facilities and extend through successful reentry.

Does COSSUP address both the supply and demand sides of the overdose crisis?

Yes. The description states that COSSUP supports practical work addressing both supply (for example, disrupting unlawful distribution networks) and demand (for example, prevention, naloxone access, treatment, and recovery support).

Is the program limited to opioid-focused work only?

No. While opioids are a central focus, the description also includes stimulants and other substances, and it frames the program around overdose deaths and broader harms tied to multiple illicit substances.

What kinds of partners are expected to be involved in a COSSUP approach?

The core focus is on coordinated strategies that bring together public safety, public health, and community partners.